An open‐label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
- DOI
- 10.1046/j.1365-2036.2002.01273.x
- Published
- 2002-05-27
- Container
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1046/j.1365-2036.2002.01273.x,
title = {An open‐label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease},
author = {J. M. Sabate and J. Villarejo and M. Lemann and J. Bonnet and M. Allez and R. Modigliani},
year = {2002},
journal = {Alimentary Pharmacology \& Therapeutics},
doi = {10.1046/j.1365-2036.2002.01273.x},
url = {https://doi.org/10.1046/j.1365-2036.2002.01273.x}
}RIS
TY - JOUR TI - An open‐label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease AU - J. M. Sabate AU - J. Villarejo AU - M. Lemann AU - J. Bonnet AU - M. Allez AU - R. Modigliani PY - 2002 JO - Alimentary Pharmacology & Therapeutics DO - 10.1046/j.1365-2036.2002.01273.x UR - https://doi.org/10.1046/j.1365-2036.2002.01273.x ER -
APA
Sabate, J. M., Villarejo, J., Lemann, M., Bonnet, J., Allez, M., & Modigliani, R. (2002). An open‐label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2002.01273.x
Source records
- crossref · retrieved 2026-09-27T11:02:57.269Z